通过基于过敏原提取物的免疫疗法疫苗,异质诱导阻断抗体对抗草过敏原分子

Lauriana-Eunice Zbîrcea1,2, Maria-Roxana Buzan1,2, Manuela Grijincu1,2

  • 1Center of Immuno-Physiology and Biotechnologies, Department of Functional Sciences, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Vaccines
|June 27, 2024
PubMed
概括

这项研究比较了四种草过敏免疫治疗疫苗,发现Diater Depot和CLUSTOID诱导了显著的IgG抗体. 高IgG水平与阻断过敏反应相关,这表明IgG是有效的无草过敏免疫治疗的标记物.